Home › Neoplasie del sangue › New Jersey › Edison
Studi clinici su Neoplasie del sangue a Edison, NJ
13 studi su Neoplasie del sangue cercano partecipanti presso sedi a Edison e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
In reclutamentoFase 3
- Cancer Institute of New Jersey ( Site 0025), New Brunswick · a 3 mi di distanza
Rutgers University Study of the Genetics of Blood Cancers
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Rutgers University, Piscataway · a 2 mi di distanza
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
In reclutamentoFase 1
- Rutgers Cancer Institute of New Jersey, Piscataway · a 2 mi di distanza
Genomic Profiling in Cancer Patients
In reclutamentoStudio osservazionale
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi di distanza
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
In reclutamentoFase 2
- Astera Cancer Care ( Site 2732), East Brunswick · a 6 mi di distanza
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
In reclutamentoFase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi di distanza
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
In reclutamentoFase 3
- Rutgers Biomedical and Health Sciences, New Brunswick · a 3 mi di distanza
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
In reclutamentoFase 1
- START New Jersey, East Brunswick · a 6 mi di distanza
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
In reclutamentoFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi di distanza
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · a 3 mi di distanza
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
In reclutamentoFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi di distanza
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
In reclutamentoVolontari sani benvenuti
- Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge · a 15 mi di distanza
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
In reclutamentoFase 1
- Rutgers Cancer Institute, New Brunswick · a 3 mi di distanza
Studi su Neoplasie del sangue in altre città
- Houston, TX46 studi
- New York City, NY26 studi
- Boston, MA25 studi
- Washington, DC19 studi
- Baltimore, MD18 studi
- Seattle, WA18 studi
- Los Angeles, CA17 studi
- Durham, NC16 studi
- Chicago, IL15 studi
- Philadelphia, PA14 studi
- Nashville, TN13 studi
- Atlanta, GA13 studi
Altri studi a Edison
- Cancro al seno68 studi
- Cancro del polmone non a piccole cellule47 studi
- Cancro (tutti i tipi)33 studi
- Cancro alla prostata29 studi
- Cancro colorettale23 studi
- Cancro ai polmoni23 studi
- Mieloma multiplo22 studi
- Cancro della vescica21 studi
- Cancro metastatico20 studi
- Cancro ovarico20 studi
- Leucemia mieloide acuta20 studi
- Cancro dell'endometrio19 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.